RE:CD8+ TiLs and T-cell exhaustion" Patients with early-stage triple-negative breast cancer (TNBC) who had breast tissue with more tumor-infiltrating lymphocytes (TIL) and did not receive adjuvant or neoadjuvant chemotherapy had significantly better survival, according to findings from a study published in JAMA."
https://www.cancernetwork.com/view/survival-outcomes-improve-with-til-presence-in-tnbc